These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 22998604)
1. Evidence of lifestyle modification in the management of hypercholesterolemia. Mannu GS; Zaman MJ; Gupta A; Rehman HU; Myint PK Curr Cardiol Rev; 2013 Feb; 9(1):2-14. PubMed ID: 22998604 [TBL] [Abstract][Full Text] [Related]
2. Systematic review on evidence of the effectiveness of cholesterol-lowering drugs. Gupta A; Guyomard V; Zaman MJ; Rehman HU; Myint PK Adv Ther; 2010 Jun; 27(6):348-64. PubMed ID: 20533012 [TBL] [Abstract][Full Text] [Related]
3. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol. Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease. Ho KT; Chin KW; Ng KS; Alemao E; Rajagopalan S; Yin D Am J Cardiovasc Drugs; 2006; 6(6):383-91. PubMed ID: 17192128 [TBL] [Abstract][Full Text] [Related]
6. The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening program. Wang JS; Carson EC; Lapane KL; Eaton CB; Gans KM; Lasater TM Prev Med; 1999 Mar; 28(3):221-8. PubMed ID: 10072739 [TBL] [Abstract][Full Text] [Related]
7. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Allen JK; Blumenthal RS; Margolis S; Young DR; Miller ER; Kelly K Am Heart J; 2002 Oct; 144(4):678-86. PubMed ID: 12360165 [TBL] [Abstract][Full Text] [Related]
8. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. Kim HS; Wu Y; Lin SJ; Deerochanawong C; Zambahari R; Zhao L; Zhang Q; Yan P Curr Med Res Opin; 2008 Jul; 24(7):1951-63. PubMed ID: 18547466 [TBL] [Abstract][Full Text] [Related]
9. Prevention of coronary heart disease. Part I. Primary prevention. Liebson PR; Amsterdam EA Dis Mon; 1999 Dec; 45(12):497-571. PubMed ID: 10711300 [TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein apheresis: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505 [TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy. Föger B; Jennings C; Pirillo A; Tokgözoğlu L; Pirro M; Catapano AL Atheroscler Suppl; 2020 Dec; 42():e25-e29. PubMed ID: 33589220 [TBL] [Abstract][Full Text] [Related]
12. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
13. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165 [TBL] [Abstract][Full Text] [Related]